Halozyme sees no impact on royalties after EU body revokes J&J’s Darzalex patent Markets March 15, 2023 [ad_1] miteman Halozyme Therapeutics (NASDAQ:HALO) mentioned the Opposition Division of the European Patent Workplace revoked a Janssen’s European Patent associated…
